Silihan lan utang jangka dawa perusahaan Dare Bioscience Inc. (DARE)

Daré Bioscience, Inc. - logo grafis emiten DARE

Dare Bioscience, Inc. (DARE) is a biotech developer creating advanced gynecological products with a focus on local component delivery. This price chart confirms the asset's dynamics, where long-term debt stands at 0.00. Dare Bioscience, Inc. (DARE) generates revenue through the sale of contraceptives and menopause therapies in collaboration with specialized clinics. The company protects its market position through patent law and a partnership with Organon, which ensures a steady influx of consumers.

DARE Dare Bioscience, Inc.: Utang jangka dawa perusahaan ing interval 04.07.2022 - 28.10.2026
Produk seri Dare Bioscience, Inc.

The dynamics of liabilities with a maturity of more than one year directly reflect the ability of cash flows to service the debt load, capturing the total volume of loans and bonds. For Dare Bioscience, Inc. (DARE), which invests in clinical development through strategic alliances, analyzing the company's long-term debt chart allows for the differentiation of financial degradation risks from targeted funding for expansion within the women's healthcare sector.